Parratto N P, Kimura A K
Department of Pathology, University of Florida College of Medicine, Gainesville 32610.
J Cell Biochem. 1988 Mar;36(3):311-22. doi: 10.1002/jcb.240360311.
Metastatic variants of the B16 melanoma displaying high experimental metastatic potential have been shown to express high levels of a 72,000-dalton glycoprotein (Met-72) on their cell surface (Kimura AK, Xiang J: J Nat Can Inst 76:1247-1253, 1986). Monoclonal antibodies (MoAb) directed against the Met-72 determinant have been used in this study as immunohistochemical reagents on preparations of fresh B16 melanoma tumors and their metastases. These immunohistochemical analyses have utilized frozen sections, impression smears, and cytospin preparations of fresh tumors harvested at various time points during tumor growth, to view the presence and location of Met-72-positive metastatic variants within tumor masses. Biotinylated anti-Met-72 MoAbs were reacted with freshly dissociated tumor cells from a B16 melanoma ovarian metastasis. These cells were then reacted with fluorescein isothiocyanate (FITC)-streptavidin and analyzed by flow cytometry. A discrete population of positively staining cells was detected and isolated by cell sorting techniques. Met-72-positive cells were then cloned and reanalyzed after several weeks of in vitro expansion and found to have high experimental metastatic potential to ovaries. Frozen sections of subcutaneous tumors and their metastases were analyzed by immunoperoxidase techniques. A consistent finding in these studies has been that the few tumor cells which showed high intensity of Met-72 staining were positioned perivascularly and at the invading front of B16 melanoma tumors.
已显示具有高实验性转移潜能的B16黑色素瘤转移变体在其细胞表面表达高水平的72,000道尔顿糖蛋白(Met-72)(Kimura AK,Xiang J:J Nat Can Inst 76:1247 - 1253,1986)。针对Met-72决定簇的单克隆抗体(MoAb)在本研究中用作新鲜B16黑色素瘤肿瘤及其转移灶制剂的免疫组织化学试剂。这些免疫组织化学分析利用了在肿瘤生长的不同时间点收获的新鲜肿瘤的冰冻切片、印片和细胞离心涂片制剂,以观察肿瘤块内Met-72阳性转移变体的存在和位置。将生物素化的抗Met-72 MoAb与来自B16黑色素瘤卵巢转移灶的新鲜解离肿瘤细胞反应。然后将这些细胞与异硫氰酸荧光素(FITC)-链霉亲和素反应,并通过流式细胞术进行分析。通过细胞分选技术检测并分离出一群阳性染色细胞。然后将Met-72阳性细胞克隆,并在体外扩增数周后重新分析,发现其对卵巢具有高实验性转移潜能。通过免疫过氧化物酶技术分析皮下肿瘤及其转移灶的冰冻切片。这些研究中一个一致的发现是,少数显示Met-72染色强度高的肿瘤细胞位于血管周围和B16黑色素瘤肿瘤的侵袭前沿。